Enhanced Lacrimal System for Targeted Ocular Drug Delivery

An improved lacrimal system for targeted drug delivery to the eye, featuring innovative designs and technologies to enhance fluid retention, flow control, and patient comfort.

The original lacrimal system for drug delivery faced limitations in fluid overflow, inconsistent flow rates, and inadequate medication customization. The new inventive concept addresses these issues by introducing advanced features and materials to optimize ocular drug delivery.

The enhanced lacrimal system comprises a reservoir balloon with an improved exit port design, reducing fluid overflow and increasing ocular surface retention. The tube features a modified lumen configuration for enhanced fluid flow control, and a protective sleeve with a built-in sensor for monitoring fluid delivery rates. Additionally, the system can be programmed to automatically adjust fluid flow rates based on real-time sensor data and ocular surface conditions. The system also features a reservoir balloon with a built-in heating or cooling element to enhance fluid solubility and stability, a tube with an integrated mixing mechanism for preparing customized medication compositions, and a protective sleeve with a self-cleaning feature to minimize bacterial contamination. Furthermore, the system can be configured to receive patient-specific data and adapt fluid delivery rates and medication compositions accordingly.

The new inventive concept introduces a novel combination of advanced features, including the improved exit port design, modified lumen configuration, built-in sensor, and adaptive fluid flow control. These features, along with the integration of heating or cooling elements, mixing mechanisms, and self-cleaning features, provide a significant improvement over the original lacrimal system and demonstrate a non-obvious inventive step.

Alternative embodiments of the enhanced lacrimal system could include variations in the reservoir balloon material, tube geometry, and sensor design. Additionally, the system could be adapted for use in other ocular or nasal applications, or integrated with other medical devices to provide a comprehensive treatment platform.

The enhanced lacrimal system has significant commercial potential in the ophthalmic and pharmaceutical industries, offering a targeted and efficient means of delivering medications to the eye. The system's adaptability and customization capabilities make it an attractive solution for a wide range of ocular conditions and diseases, with potential applications in glaucoma treatment, dry eye management, and beyond.